Navigation Links
OpenClinica EDC Solution Deployed for Retina Implant Studies
Date:8/20/2008

German medical device company, Retina Implant, AG has selected OpenClinica as its electronic data capture (EDC) and clinical data management (CDM) system to power its clinical trials.

Ruetlingen, Germany (PRWEB) August 20, 2008 -- German medical device company, Retina Implant, AG has selected OpenClinica as its http://www.openclinica.org/section.php?sid=1 [electronic data capture (EDC) __title__ EDC software] and clinical data management (CDM) system to power its clinical trials. The company's primary product is a novel retinal prosthesis that in many ways is analogous to the popular cochlear implant used as a hearing prosthesis. The device will primarily be used to treat Retinitis Pigmentosa (RP) and Age-related Macular Degeneration (AMD).

"We are currently using OpenClinica for 11 trials with sites in Germany, India, and Brazil, and we plan to use it for new studies with sites in the U.S. as well," said Anusch Hekmat, VP of Quality Management & Regulatory Affairs at Retina Implant. "As a small medical device company, the professional open source approach behind OpenClinica makes a lot of sense. It allows us to be highly adaptable in how we administer our clinical trials while providing us with high quality professional support in key areas."

Selecting, implementing, and supporting a sound, regulatory compliant system for clinical trial data management can be challenging for smaller biotech companies. Retina Implant is among numerous other biotech and pharmaceutical companies who enjoy the flexibility and compelling value of a professionally supported open source solution.

"OpenClinica removes many of the constraints that proprietary vendors tend to put on their clients," said Ben Baumann, Director of Business Development at Akaza Research, the creators of OpenClinica. "OpenClinica gives the research sponsor much greater latitude in how they implement and support their systems. This is becoming increasingly important as research grows in expense and complexity."

About Retina Implant AG:
Founded in 2003, Retina Implant AG is building upon the results of a research project in which numerous German university hospitals and German research institutes have participated since 1996. The company plans to bring to market the first fully functioning electronic retinal prosthesis, in order to help restore sight to people who have a degenerative retinal disease such as Retinitis Pigmentosa (RP) and Age-related Macular Degeneration (AMD). For more information, see http://www.retina-implant.de/.

About OpenClinica®:
OpenClinica is open source web-based electronic data capture software for clinical research. It facilitates protocol configuration, design of case report forms, clinical data capture, and study/data management. OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. All versions of OpenClinica are available for download at http://www.openclinica.org.

About Akaza Research®:
Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data capture and management software platform. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for all types of clinical research. Akaza Research provides OpenClinica support, training, and consulting services to its customers worldwide. See http://www.akazaresearch.com.

# # #

Read the full story at http://www.prweb.com/releases/2008/08/prweb1176494.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
2. Cascade Controls Changes Corporate Identity to Cascade Solutions
3. Aureus Pharma Releases AurPROFILER(R) - a New and Powerful Pharmacology Profiling Solution
4. BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts
5. StollerUSA Launches Bio-Forge.com to Offer Solutions for Crops Under Stress
6. PerkinElmer Expertise and Solutions Integral to Food Safety Monitoring for the Beijing Games : Methods, Applications Expertise and Instrumentation Deployed in Mobile Laboratory
7. TriMix Laboratories Announces New Partnership With American Pharmacy Solutions
8. NanoLogix Inc. Announces Joint Development With CL Solutions and First Sales of Rapid Detection Kits
9. Protein Sciences Announces Termination of Deal to Sell to Emergent BioSolutions
10. Advanced Bionics Reaches Resolution With FDA, Settles Financial Suit
11. Super-resolution X-ray microscopy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
OpenClinica EDC Solution Deployed for Retina Implant Studies
(Date:5/26/2017)... ... May 25, 2017 , ... Throughout this webinar, participants will ... process development and economic goals were achieved in both industry and academic settings. ... system, along with techniques for scaling production of mesenchymal stem cells (MSCs) and ...
(Date:5/24/2017)... ... May 23, 2017 , ... ... high quality relocatable and permanent modular buildings, announced the launch of the ... modern office design characteristics to help support on-site teamwork and collaboration. , ...
(Date:5/23/2017)... , ... May 23, 2017 , ... A recent survey ... most troublesome and difficult to control weed in 12 categories of broadleaf crops, fruits ... 200 weed scientists across the U.S. and Canada participated in the 2016 survey, the ...
(Date:5/23/2017)... ... , ... Vortex Biosciences , provider of circulating tumor cell (CTC) capture ... using Vortex microfluidic technology ” in Nature Precision Oncology on May 8th. The ... and Dr. Matthew Rettig at the University of California, Los Angeles. The publication describes ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
Breaking Biology News(10 mins):